In this lecture, Dr. Dugan discusses the history of tobacco use and reviews the medications that may be effective for smoking cessation. By the end of this lecture, you will be able to: 1) identify pharmacologic targets for treatment of tobacco use disorder, 2) list the adverse effects seen with pharmacologic treatment of tobacco use disorder, and 3) compare the efficacy data for agents used for treatment of tobacco use disorder.
Tag: dose
Optimal Pharmacotherapy for Schizoaffective Disorder
In this lecture, Dr. Dugan discusses medications that might be useful in treating schizoaffective disorder. By the end of this lecture, you will be able to: 1) describe the pharmacotherapeutic medications used for the treatment of schizoaffective disorder (SAD) and 2) compare the efficacy and safety data of different medications for the treatment of patients with SAD.
Drug Interactions with Psychiatric Medications
In this lecture, Dr. Dugan covers the basics of drug metabolism and highlights several important psychiatric drug-drug interactions that patients as well as prescribers should be aware of. By the end of this lecture, you will be able to: 1) compare pharmacodynamic and pharmacokinetic drug interactions and 2) identify relevant drug interactions with medications used in the treatment of mental illnesses.
What are the risks of Lithium and How to use it safely?
In this lecture, Dr. Dugan takes a look at the risk profile of lithium and discusses ways to use it safely. By the end of this lecture, you will be able to: 1) list the indications for use of lithium, 2) identify short- and long-term adverse effects associated with lithium use, and 3) compare monitoring recommendations for patients on lithium.
Antipsychotics
In this lecture, Dr. Dugan addresses the proper dosing of antipsychotic medication. By the end of this lecture, you will be able to: 1) identify biological, social, and psychological factors that affect psychotic illness, 2) define the mechanisms or rationale for treatments appropriate for psychotic illness, and 3) integrate biological, social, and psychological considerations when designing and implementing treatment of individuals affected by psychotic illness.
